Pianigiani T, Paggi I, Cooper G, Staples K, McDonnell M, Bergantini L
ERJ Open Res. 2025; 11(2).
PMID: 40071269
PMC: 11895099.
DOI: 10.1183/23120541.00683-2024.
Duan X, Lv X, Wang X, Zhang Y, Hu Y, Li H
Commun Biol. 2025; 8(1):405.
PMID: 40065158
PMC: 11893770.
DOI: 10.1038/s42003-025-07816-3.
Cho S, Choi S, Maeng E, Park H, Ryu K, Park K
J Immunother Cancer. 2025; 13(3).
PMID: 40044578
PMC: 11883546.
DOI: 10.1136/jitc-2024-010371.
Wang Y, He X, Yang C, Ding J
Front Med (Lausanne). 2025; 12:1513213.
PMID: 40034381
PMC: 11872723.
DOI: 10.3389/fmed.2025.1513213.
Hong T, Pu D, Wu J
Front Endocrinol (Lausanne). 2025; 16:1456273.
PMID: 40026688
PMC: 11868816.
DOI: 10.3389/fendo.2025.1456273.
STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis.
Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B
Bioimpacts. 2025; 15:30030.
PMID: 39963570
PMC: 11830145.
DOI: 10.34172/bi.30030.
Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit.
Epelbaum O, de Moraes A, Olson J, Lionakis M
Intensive Care Med. 2025; 51(2):364-377.
PMID: 39961846
PMC: 11903580.
DOI: 10.1007/s00134-025-07797-1.
CD94-driven expansion of highly functional adaptive NKG2C NKG2A CD57 NK cells from CMV healthy donors.
Giordano C, Carlomagno S, Falco M, Cantoni C, Vitale M, Caruana I
Front Immunol. 2025; 16:1481745.
PMID: 39958331
PMC: 11825780.
DOI: 10.3389/fimmu.2025.1481745.
NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.
Sanchez-Gaona N, Perea D, Curran A, Burgos J, Navarro J, Suanzes P
Commun Biol. 2025; 8(1):236.
PMID: 39953264
PMC: 11829058.
DOI: 10.1038/s42003-025-07651-6.
Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.
Pfnur A, Mayer B, Dorfer L, Tumani H, Spitzer D, Huber-Lang M
Int J Mol Sci. 2025; 26(3).
PMID: 39941044
PMC: 11818301.
DOI: 10.3390/ijms26031276.
Natural Killer Cells in Graves' Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls.
Gallo D, Piantanida E, Bombelli R, Lepanto S, Bruno A, Gallazzi M
Int J Mol Sci. 2025; 26(3).
PMID: 39940745
PMC: 11816991.
DOI: 10.3390/ijms26030977.
Rapid Natural Killer Cell Gene Responses, Generated by TLR Ligand-Induced Trained Immunity, Provide Protection to Bacterial Infection in Mutant Zebrafish ().
Muire P, Hanson L, Petrie-Hanson L
Int J Mol Sci. 2025; 26(3).
PMID: 39940731
PMC: 11818001.
DOI: 10.3390/ijms26030962.
Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.
Zuniga C, Acosta B, Menchaca R, Amescua C, Hong S, Hui L
Alzheimers Res Ther. 2025; 17(1):40.
PMID: 39939891
PMC: 11817217.
DOI: 10.1186/s13195-025-01681-2.
Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6.
Woelk J, Hornsteiner F, Aschauer-Wallner S, Stoitzner P, Baier G, Hermann-Kleiter N
Cell Death Dis. 2025; 16(1):77.
PMID: 39920136
PMC: 11806049.
DOI: 10.1038/s41419-025-07407-4.
Zinc Deficiency Associated With an Increase in Mortality in COVID-19 Patients: A Meta-Analysis.
Raval C, Rheingold S, Gordon A, Hardigan P
Cureus. 2025; 17(1):e77011.
PMID: 39912051
PMC: 11798623.
DOI: 10.7759/cureus.77011.
inhibits the cytotoxicity of primary natural killer cells.
Abdelbary R, Ragheb M, El Sobky S, El-Badri N, Aboud N, Tawheed A
Front Oncol. 2025; 14:1523068.
PMID: 39906666
PMC: 11790671.
DOI: 10.3389/fonc.2024.1523068.
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies.
Wang Q, Yu M, Zhang S
Front Immunol. 2025; 15:1440830.
PMID: 39877377
PMC: 11772360.
DOI: 10.3389/fimmu.2024.1440830.
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.
Lei Y, Liu J, Bai Y, Zheng C, Wang D
Pharmaceutics. 2025; 17(1).
PMID: 39861694
PMC: 11768547.
DOI: 10.3390/pharmaceutics17010046.
Natural killer cells occupy unique spatial neighborhoods in HER2 and HER2 human breast cancers.
Ehlers F, Blise K, Betts C, Sivagnanam S, Kooreman L, Hwang E
Breast Cancer Res. 2025; 27(1):14.
PMID: 39856748
PMC: 11762118.
DOI: 10.1186/s13058-025-01964-4.
The diversity of natural killer cell functional and phenotypic states in cancer.
Rishabh K, Matosevic S
Cancer Metastasis Rev. 2025; 44(1):26.
PMID: 39853430
DOI: 10.1007/s10555-025-10242-w.